Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Synthorx, Inc, A Sanofi Company

Clinical trials sponsored by Synthorx, Inc, A Sanofi Company, explained in plain language.

Now part of Sanofi S.A. SNY NASDAQ

A biotech company developing expanded genetic code-based therapies, acquired by Sanofi.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Experimental cancer drug THOR-707 tested in patients with advanced tumors

Disease control Terminated

This study tested an experimental drug called THOR-707 in adults with advanced solid tumors that had spread. The goal was to find safe doses and see if the drug could shrink tumors when used alone or with other treatments. The study was stopped early, so results are limited.

Phase: PHASE1, PHASE2 • Sponsor: Synthorx, Inc, a Sanofi company • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC